CN111675672A - Method for preparing astallurens - Google Patents
Method for preparing astallurens Download PDFInfo
- Publication number
- CN111675672A CN111675672A CN202010397868.5A CN202010397868A CN111675672A CN 111675672 A CN111675672 A CN 111675672A CN 202010397868 A CN202010397868 A CN 202010397868A CN 111675672 A CN111675672 A CN 111675672A
- Authority
- CN
- China
- Prior art keywords
- methyl
- preparing
- benzoate
- fluorophenyl
- oxadiazolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims abstract description 13
- BELBATQPRYKIIA-UHFFFAOYSA-N methyl 3-[(z)-n'-hydroxycarbamimidoyl]benzoate Chemical compound COC(=O)C1=CC=CC(C(N)=NO)=C1 BELBATQPRYKIIA-UHFFFAOYSA-N 0.000 claims abstract description 11
- XPBHWSMZTSSEJE-UHFFFAOYSA-N methyl 3-cyanobenzoate Chemical compound COC(=O)C1=CC=CC(C#N)=C1 XPBHWSMZTSSEJE-UHFFFAOYSA-N 0.000 claims abstract description 10
- RAAGZOYMEQDCTD-UHFFFAOYSA-N 2-fluorobenzoyl chloride Chemical compound FC1=CC=CC=C1C(Cl)=O RAAGZOYMEQDCTD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940095102 methyl benzoate Drugs 0.000 claims abstract description 9
- -1 tetraalkylammonium halide Chemical class 0.000 claims abstract description 7
- 238000005917 acylation reaction Methods 0.000 claims abstract description 6
- 239000012046 mixed solvent Substances 0.000 claims abstract description 5
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 230000003197 catalytic effect Effects 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 10
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 230000006179 O-acylation Effects 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 5
- UXOWGYHJODZGMF-QORCZRPOSA-N Aliskiren Chemical compound COCCCOC1=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=CC=C1OC UXOWGYHJODZGMF-QORCZRPOSA-N 0.000 claims description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 229960004601 aliskiren Drugs 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 claims description 2
- FDDKULNHLFGRDK-UHFFFAOYSA-N arturin Natural products CC=C(C)C(=O)OC1CC2(C)C(O)CCC(=C)C2C2C1C(=C)C(=O)O2 FDDKULNHLFGRDK-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 abstract description 10
- OOUGLTULBSNHNF-UHFFFAOYSA-N 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C=2N=C(ON=2)C=2C(=CC=CC=2)F)=C1 OOUGLTULBSNHNF-UHFFFAOYSA-N 0.000 abstract description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 229960003995 ataluren Drugs 0.000 abstract description 5
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 5
- 238000001308 synthesis method Methods 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- HEDOIGKHYJPQHF-UHFFFAOYSA-N [(e)-[amino-(3-methoxycarbonylphenyl)methylidene]amino] 2-fluorobenzoate Chemical compound COC(=O)C1=CC=CC(C(\N)=N/OC(=O)C=2C(=CC=CC=2)F)=C1 HEDOIGKHYJPQHF-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 1
- RPESZQVUWMFBEO-UHFFFAOYSA-N 3-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(C#N)=C1 RPESZQVUWMFBEO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical compound C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- IBAHLNWTOIHLKE-UHFFFAOYSA-N cyano cyanate Chemical compound N#COC#N IBAHLNWTOIHLKE-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
The invention discloses a method for preparing atraurone (Ataluren, PTC124, trade name Translarna), belonging to the field of organic synthesis. Methyl m-cyanobenzoate and hydroxylamine hydrochloride react in lower alcohol or a mixed solvent of the lower alcohol and water to generate 3- (N-hydroxyamidino) -methyl benzoate; o-acylation reaction of methyl 3- (N-hydroxycarbamimidoyl) -benzoate and O-fluorobenzoyl chloride in organic solvent to obtain methyl 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoate; carrying out cyclization under the catalytic action of tetraalkylammonium halide to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate; fourthly, hydrolyzing to obtain the atractylen. The invention is a simple and high-efficiency synthesis method of the astallurens.
Description
Technical Field
The invention relates to a method for preparing atraumatic, belonging to the field of organic synthesis.
Background
Attulellan, english name: ataluren, trade name: (Translarna), chemical name: 3- ((5- (2-fluorophenyl)) - (1,2, 4-oxadiazol-3-yl)) -benzoic acid. Is a small molecule oral drug developed by PTC in the united states for the treatment of nonsense-mutated Duchenne muscular dystrophy (Duchenne and Becker) and cystic fibrosis, and is currently marketed in europe and in phase iii in the united states. During translation of mRNA, ribosomes are allowed to pass over the stop codon that appears prematurely in the mRNA, allowing normal genetic information to be read and the synthesis of a fully functional protein. The structure of astallurone is as follows:
in the prior art, the methyl m-cyanobenzoate is generally reacted with hydroxylamine hydrochloride to produce the methyl 3- (N-hydroxyamidino) -benzoate. The ester is subjected to O-acylation reaction with O-fluorobenzoyl chloride to obtain 3- (N- (2-fluorobenzoyloxy) amidino) -methyl benzoate, and cyclization is carried out to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate. Hydrolyzing under alkaline condition to obtain the alpha-gulen.
The method for synthesizing the atraumatic in the patent CN101535284A comprises the following steps: the method comprises the steps of adopting a one-pot method to prepare alpha-methyl cyanobenzoate as an initial raw material, carrying out a reaction with hydroxylamine hydrochloride, carrying out an O-acylation reaction on O-fluorobenzoyl chloride, cyclizing to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate, and hydrolyzing under an acidic condition to obtain alpha-lulan. The reaction time was about 63 hours, with 32 hours for the cyclization reaction to proceed, and the overall yield was 67%. The reaction time is long, the intermediate is not separated, and impurities in the final product are complex.
WO2004091502A/US6992096 is similar to CN101535284A, but the reaction is carried out step by step, O-acylation and cyclization are carried out on O-fluorobenzoyl chloride by taking toluene as a solvent, a water separation device is arranged, reflux is carried out for 4 hours at 130 ℃, and then stirring is carried out for 18 hours at 5 ℃.
Laura Lentini, Raffaella Melfi, Aldo Di Leonardo et al published in molecular pharmaceuticals (2014, 11, 653-664) introduced the synthesis of Altaluron by using 3-cyanobenzoyl chloride as raw material, esterification, acylation-cyclization, and catalytic hydrolysis of boron trifluoride as solvent to obtain Altaluron with a total yield of 40%.
There are generally two methods by which the basic parent 1,2, 4-oxadiazole in the molecular structure of arabinls can be obtained. Firstly, the 1, 3-dipolar cycloaddition between cyano group of nitrile compound and cyano oxide is difficult to obtain raw material, the specificity of reaction is poor, and the product is complex. Another method is the cyclization of aminooxime derivatives. Aminooxime derivatives are readily prepared by reacting a cyano group with hydroxylamine followed by acylation with carboxylic acids and their derivatives. Therefore, the latter method is often used for the synthesis of astallurens.
The existing synthetic technical route of the atralon is analyzed, so that the amino oxime derivative synthesized in the first step and the second step is relatively mature reaction, and the yield is relatively high. The cyclization reaction is the technical key of the whole synthesis process. The reaction type of the step belongs to nucleophilic addition-elimination reaction, the reaction speed is low, the efficiency is low along with the rise of the reaction temperature and the extension of the reaction time, the purification is not easy, and the side products generated by cyclization with the amino oxime are increased, so that the yield and the purity of the final product are influenced. The invention adopts the catalyst to catalyze and make the cyclization reaction of the amidoxime O-acylated derivative easy to carry out.
Disclosure of Invention
The invention aims to solve the technical problem of providing a method for preparing the atraumatic, and the invention is a simple and efficient atraumatic synthesis method.
The technical scheme adopted by the invention is as follows: a method of preparing artoluron, comprising the steps of:
(1) adding methyl m-cyanobenzoate and hydroxylamine hydrochloride into a low molecular alcohol or a low molecular alcohol aqueous solution, and reacting in the presence of alkali to generate 3- (N-hydroxyamidino) -methyl benzoate;
(2) putting the ester obtained in the step (1) and O-fluorobenzoyl chloride into an organic solvent for O-acylation reaction to obtain 3- (N- (2-fluorobenzoyloxy) amidino) -methyl benzoate;
(3) cyclizing the ester obtained in the step (2) under the action of a quaternary ammonium salt catalyst to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate;
(4) hydrolyzing the ester obtained in the step (3) under an alkaline condition to obtain the aliskiren.
Preferred catalysts are quaternary ammonium salts of the formula R4N+X-R is C1-C16In chain hydrocarbon radicals
And X is one of Cl, Br, I or F.
The preferred catalyst is one of quaternary ammonium salts tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium iodide or tetrabutylammonium fluoride.
The preferred catalyst is the quaternary ammonium salt tetrabutylammonium fluoride.
The preferred lower alcohol is one of methanol, ethanol or isopropanol.
The preferable molar ratio of the catalyst to the methyl m-cyanobenzoate is 0.05-1: 1.
In a preferable mixed solvent of lower alcohol and water, the ratio of alcohol to water is 10-1: 1.
The preferred base is one of sodium carbonate, potassium carbonate, sodium hydroxide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide, triethylamine or diisopropylethylamine.
The preferable organic solvent is one of dichloromethane, tetrahydrofuran, dimethylformamide, acetonitrile, ethylene glycol dimethyl ether or acetone.
In the preparation process of the important intermediate 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate of the alpha-toluron, methyl m-cyanobenzoate is used as a raw material to react with hydroxylamine hydrochloride to generate the methyl 3- (N-hydroxyamidino) -benzoate. Followed by O-acylation with O-fluorobenzoyl chloride to give methyl 3- (N- (2-fluorobenzoyloxy) amidino) -benzoate. At room temperature, the methyl 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoate is obtained through catalytic cyclization. Hydrolyzing under alkaline condition to obtain the alpha-gulen.
The synthetic route is as follows:
adopt the produced beneficial effect of above-mentioned technical scheme to lie in: the method is simple and efficient, and can obviously shorten the reaction time on the premise of ensuring the product yield. The total yield of the preparation method of the atractylen can reach 68%, and the purity of the prepared atractylen can reach more than 99.0% after once crystallization.
The specific implementation mode is as follows:
preparation of methyl 3- (N-hydroxycarbamimidoyl) -benzoate
(1) Methyl m-cyanobenzoate (80.1 g, 0.5 mol) in ethanol (800 mL) was added hydroxylamine hydrochloride (68.5 g, 1.0 mol) and sodium ethoxide (68.05 g, 1.0 mol). The reaction was stirred at room temperature for 20 h and the solvent was evaporated under reduced pressure. Ethyl acetate (500 mL) was added to the residue, which was filtered and evaporated under reduced pressure to give a crude product, which was slurried with water, filtered and dried to give 92.5 g of methyl 3- (N-hydroxycarbamimidoyl) -benzoate as a white solid with a yield of 95% and mp.101-102.1 ℃. MS (M/z): 195[ M + H]+。
1H-NMR(400 MHz,DMSO-d 6 ): 9.83 (s,1H),8.41 (d,1H;J= 0.9 Hz),8.01(t,1H;J= 7.5 Hz),7.56 (t,1H;J= 7.5 Hz),6.02 (s,2H),3.95 (s,3H)。
(2) Methyl m-cyanobenzoate (12 g, 74.4 mmol) was dissolved in methanol (240 mL), and hydroxylamine hydrochloride (12.8 g, 186 mmol) was added with stirring. A solution of sodium methoxide (11.8 g, 186 mmol) in methanol (240 mL) was added dropwise to the reaction mixture, the mixture was reacted at room temperature for 20 hours, methanol was distilled off under reduced pressure, ethyl acetate (300 mL) was added, the mixture was filtered, and ethyl acetate was distilled off under reduced pressure to obtain a crude product, which was slurried with water, filtered, and dried to obtain methyl 3- (N-hydroxycarbamimidoyl) -benzoate as a white solid in a yield of 87%.
(3) Hydroxylamine hydrochloride (32.1 g, 0.468 mol) and sodium carbonate (32.6 g, 0.31 mol) were added to a solution of methyl m-cyanobenzoate (50.0 g, 0.31 mol) in ethanol (500 mL), stirred at room temperature, water (200 mL) was added, and stirring was continued for 16 h. The reaction mixture was poured into 500mL of ice water, filtered to give the crude product, which was recrystallized from ethyl acetate-N-hexane to give methyl 3- (N-hydroxycarbamimidoyl) -benzoate as a white solid, 43.95g, 73%.
Preparation of methyl 3- (N-2-fluorobenzoyloxyamidyl) benzoate
(1) 3- (N-hydroxycarbamimidoyl) -benzoic acid methyl ester (120 g, 620 mmol) is dissolved in anhydrous tetrahydrofuran (400 mL), diisopropylethylamine (150 mL, 868 mmol) is added, 2-fluorobenzoyl chloride (96.2 mL, 806 mmol) is added dropwise at 5 deg.C, the mixture is stirred at room temperature for 1h, filtered, concentrated under reduced pressure, the residue is dissolved in ethyl acetate (800 mL), washed with water (250 mL × 3), dried over anhydrous sodium sulfate, the solvent is evaporated under reduced pressure and recrystallized from ethyl acetate and N-hexane (6: 4) to give a white solid, 3- (N-2-fluorobenzoyloxyamidino) benzoic acid methyl ester 175g, 89.2%.1H-NMR(400 MHz,CDCl3): 8.18(1H),8.03(2H),7.48(2H),7.18(2H),5.61(2H),3.82(3H)。
(2) Methyl 3- (N-hydroxycarbamimidoyl) -benzoate (10 g, 51.5 mmol) was dissolved in acetone (180 mL), stirred at room temperature, potassium carbonate (8.55 g, 61.87 mmol) and o-fluorobenzoyl chloride (9.81 g, 61.87 mmol) were added, stirred at room temperature for 1h, and acetone was evaporated under reduced pressure. The residue was dissolved in ethyl acetate (80 mL), washed with water (25 mL. times.3), dried over anhydrous sodium sulfate, the solvent was evaporated under reduced pressure, and the residue was recrystallized from ethyl acetate and N-hexane (6: 4) to give a white solid, methyl 3- (N-2-fluorobenzoyloxyamidino) benzoate 14 g, 86.2%.
Preparation of fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate
Methyl 3- (N-2-fluorobenzoyloxyamidyl) benzoate (63.5g, 0.2 mol) was dissolved in THF (500 mL) and tetrabutylammonium fluoride (1 mol/L in THF, 20 mL, 0.02 mol) was added dropwise at room temperature and stirred for 24 h. The mixture was poured into ethyl acetate, and washed with water and saturated brine, respectively. Drying with anhydrous sodium sulfate, decompressing to obtain a solvent, and recrystallizing with ethyl acetate-n-hexane to obtain 54.28g of white solid 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate and 91 percent. mp.133.8-136.4 ℃. MS (M/z) 299[ M + H ] +.
1H-NMR (400 MHz,DMSO-d 6): 8.78 (t,1H,J= 1.8 Hz),8.31 (dt,1H,J 1=7.8 Hz,J 2= 1.4 Hz),8.18−8.12 (m,2H),7.59−7.52 (m,2H),7.32−7.20 (m,2H),3.91(s,3H)。
Preparation of fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoic acid
Methyl 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoate (80 g, 0.268 mol) was added to a tetrahydrofuran-water (2: 1) mixed solvent (800 mL), lithium hydroxide (38.5 g) was added, the mixture was stirred at room temperature for 24 hours, the solvent was evaporated under reduced pressure, water was added for dilution, acidification was performed with hydrochloric acid to precipitate a white precipitate, and filtration and drying were performed to obtain 63.8 g, 88% of 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -benzoic acid as a white solid. mp.239.5-241.6 ℃. And (3) HPLC detection result: chemical purity of 99.8%, SunFereTMC18Chromatography column (150 mm × 4.6.6 mm, 5 μ M) with mobile phase of acetonitrile-0.1% formic acid (50: 50), MS (M/z): 285[ M + H]+。1H-NMR (400 MHz,DMSO-d 6) : 7.51(t,2H,Ar,J= 8.9 Hz),7.56(d,2H,Ar,J= 8.8Hz),8.07(m,1H,Ar),8.17-8.34 (d,2H,Ar,J= 8.9Hz),8.68 (s,1H,Ar),13.36 (brs,1 H,OH)。
Claims (9)
1. A method for preparing atraulon, which is characterized by comprising the following steps:
(1) adding methyl m-cyanobenzoate and hydroxylamine hydrochloride into lower alcohol or a mixed solvent of the lower alcohol and water, and reacting under an alkaline condition to generate methyl 3- (N-hydroxycarbamimidoyl) -benzoate;
(2) dissolving the methyl 3- (N-hydroxycarbamimidoyl) -benzoate obtained in the step (1) and o-fluorobenzoyl chloride in an organic solvent
Carrying out O-acylation reaction in a medium to obtain 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate;
(3) under the catalytic action of tetraalkylammonium halide, 3- ((5- (2-fluorophenyl)) -3- (1,2,4-
Oxadiazolyl)) -benzoic acid methyl ester;
(4) 3- ((5- (2-fluorophenyl)) -3- (1,2, 4-oxadiazolyl)) -methyl benzoate are hydrolyzed to obtain the aliskiren.
2. The process for preparing arturin according to claim 1, characterized in that said tetrahydrocarbon is
Based on the formula of the ammonium halide catalyst R4N+X-R is C1~C16One or more than two kinds of chain alkyl, X is one of Cl, Br, I or F.
3. The method for preparing attulellan according to claim 2, wherein the quaternary ammonium salt catalyst is one of tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium iodide or tetrabutylammonium fluoride.
4. The method for preparing attulellan according to claim 3, wherein the quaternary ammonium salt catalyst is tetrabutylammonium fluoride.
5. The method for preparing aliskiren according to claim 1, wherein the lower alcohol is one of methanol, ethanol, or isopropanol.
6. The method for preparing atralone according to claim 1, wherein the molar ratio of the catalyst to the methyl m-cyanobenzoate is 0.05-1: 1.
7. The method for preparing arturin according to claim 1, wherein the lower alcohol is water
The ratio of the alcohol to the water in the mixed solvent of (1) to (10).
8. A process according to claim 1, wherein the base used is an alkali
Sodium carbonate, potassium carbonate, sodium hydroxide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide, triethylamine
Or diisopropylethylamine.
9. A process for preparing aliskiren according to claim 1, wherein the organic solvent used is
The medium is one of dichloromethane, tetrahydrofuran, dimethylformamide, acetonitrile, ethylene glycol dimethyl ether or acetone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010397868.5A CN111675672A (en) | 2020-05-12 | 2020-05-12 | Method for preparing astallurens |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010397868.5A CN111675672A (en) | 2020-05-12 | 2020-05-12 | Method for preparing astallurens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111675672A true CN111675672A (en) | 2020-09-18 |
Family
ID=72452443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010397868.5A Pending CN111675672A (en) | 2020-05-12 | 2020-05-12 | Method for preparing astallurens |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111675672A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113045510A (en) * | 2021-03-31 | 2021-06-29 | 北京大学生命科学华东产业研究院 | Preparation method of astallurens |
| CN114920667A (en) * | 2022-06-30 | 2022-08-19 | 湖南大学 | A kind of electrochemical preparation method of ataluron ester |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040204461A1 (en) * | 2003-04-11 | 2004-10-14 | Karp Gary Mitchell | 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| CN104428296A (en) * | 2012-07-02 | 2015-03-18 | 孟山都技术公司 | Process for preparing 3,5-disubstituted-1,2,4-oxadiazoles |
| CN105461650A (en) * | 2014-09-12 | 2016-04-06 | 杭州普晒医药科技有限公司 | Oxdiazole compound solvate and preparation method thereof |
| WO2016073545A1 (en) * | 2014-11-06 | 2016-05-12 | Concert Pharmaceuticals, Inc. | Phenyloxadiazole benzoic acids |
| CN106279057A (en) * | 2016-08-15 | 2017-01-04 | 东莞明日医药有限公司 | The novel synthesis of Ataluren |
| TW201808922A (en) * | 2016-06-20 | 2018-03-16 | 台灣神隆股份有限公司 | Process for preparing ataluren and its intermediates |
-
2020
- 2020-05-12 CN CN202010397868.5A patent/CN111675672A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040204461A1 (en) * | 2003-04-11 | 2004-10-14 | Karp Gary Mitchell | 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| CN104428296A (en) * | 2012-07-02 | 2015-03-18 | 孟山都技术公司 | Process for preparing 3,5-disubstituted-1,2,4-oxadiazoles |
| CN105461650A (en) * | 2014-09-12 | 2016-04-06 | 杭州普晒医药科技有限公司 | Oxdiazole compound solvate and preparation method thereof |
| WO2016073545A1 (en) * | 2014-11-06 | 2016-05-12 | Concert Pharmaceuticals, Inc. | Phenyloxadiazole benzoic acids |
| TW201808922A (en) * | 2016-06-20 | 2018-03-16 | 台灣神隆股份有限公司 | Process for preparing ataluren and its intermediates |
| CN106279057A (en) * | 2016-08-15 | 2017-01-04 | 东莞明日医药有限公司 | The novel synthesis of Ataluren |
Non-Patent Citations (2)
| Title |
|---|
| ANTHONY R. GANGLOFF,ET AL.: "Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst", 《TETRAHEDRON LETTERS》 * |
| DOUGLAS S. AULD,ET AL.: "Mechanism of PTC124 activity in cell-based lucifierase assays of nonsense codon suppression", 《PNAS》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113045510A (en) * | 2021-03-31 | 2021-06-29 | 北京大学生命科学华东产业研究院 | Preparation method of astallurens |
| CN113045510B (en) * | 2021-03-31 | 2022-05-27 | 北京大学生命科学华东产业研究院 | Preparation method of atralone |
| CN114920667A (en) * | 2022-06-30 | 2022-08-19 | 湖南大学 | A kind of electrochemical preparation method of ataluron ester |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070149522A1 (en) | Method for producing 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide | |
| US20070105921A1 (en) | Process for Preparing Oxazole Intermediates | |
| RU2711358C1 (en) | Simple method of producing avibactam | |
| CN109640657B (en) | Process for preparing 4-alkoxy-3- (acyl or aliphatic saturated hydrocarbyl) oxypyridine carboxamides | |
| CN111675672A (en) | Method for preparing astallurens | |
| CN114478690B (en) | Preparation method of 6, 6-dimethyl-3-azabicyclo [3.1.0] hexane derivative | |
| CN112645833A (en) | Synthesis method of (S) -2, 6-diamino-5-oxohexanoic acid | |
| WO2011026318A1 (en) | S-5-substituent-n-2'-(thiophene-2-yl)ethyl-tetralin-2-amine or chiral acid salts thereof and use for preparing rotigotine | |
| CN102911160A (en) | Method for preparing and purifying dabigatran etexilate intermediate | |
| JP2018090551A (en) | L-carnosine derivative or salt thereof, and method for producing L-carnosine or salt thereof | |
| CN113527137A (en) | Preparation method of characteristic impurities of trifloxystrobin | |
| WO2016115962A1 (en) | Preparation method for nebivolol intermediate and preparation method for nebivolol | |
| CN101506141A (en) | 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester and method for producing the same | |
| CN115433140A (en) | Synthetic method of Aforana | |
| CN110878097B (en) | Preparation method of feigninib | |
| CN103450066B (en) | The preparation method of Telaprevir intermediate | |
| CN113264875A (en) | Synthesis method of flonicamid | |
| KR100564072B1 (en) | Method for non-pressurely preparing α, α-dimethylphenylacetic acid from α, α-dimethylbenzyl cyanide | |
| JP2001302658A (en) | Method for manufacturing of 3-isochromanones | |
| CN115819260B (en) | Synthesis process of sitagliptin intermediate | |
| CN113372235B (en) | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids | |
| JP2021526142A (en) | Process for preparing 2- (1- (tert-butoxycarbonyl) piperidine-4-yl) benzoic acid | |
| JPS5927343B2 (en) | Synthesis method of 3-aminoisoxazoles | |
| JP2001502298A (en) | Methods and new intermediates | |
| JP4368494B2 (en) | Method for producing carboxylic acid tertiary alkyl ester |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200918 |
|
| WD01 | Invention patent application deemed withdrawn after publication |